The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doerre, S.
Right arrow Articles by Corley, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doerre, S.
Right arrow Articles by Corley, R. B.
The Journal of Immunology, 2005, 174: 983-991.
Copyright © 2005 by The American Association of Immunologists

Reductions in I{kappa}B{epsilon} and Changes in NF-{kappa}B Activity during B Lymphocyte Differentiation1

Stefan Doerre*, Kristin Perkins Mesires*, Kylle M. Daley*, Thomas McCarty{dagger}, Sonja Knoetig{dagger} and Ronald B. Corley2,*

* Department of Microbiology, Boston University School of Medicine, Boston, MA 02118; and {dagger} Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892

The levels and stability of I{kappa}B{epsilon} have been examined in unstimulated and stimulated splenic B cells and compared with that of I{kappa}B{alpha} and I{kappa}B{beta}. Primary murine splenic B cells but not T cells were found to contain high levels of I{kappa}B{epsilon} protein, equivalent to levels of the abundant I{kappa}B{alpha}. Most agents that activate I{kappa}B{alpha} and I{kappa}B{beta} degradation do not induce rapid degradation of I{kappa}B{epsilon}. Interestingly, however, the levels of I{kappa}B{epsilon}, but not of I{kappa}B{alpha} or I{kappa}B{beta}, are dramatically reduced upon the stimulation of B cells both in vivo and in vitro. Since I{kappa}B{epsilon} exhibits substrate specificity for NF-{kappa}B Rel homodimers, this suggested the possibility that changes in NF-{kappa}B-responsive genes might also occur during this transition. Consistent with this hypothesis, we found that a NF-{kappa}B reporter construct sensitive to p65/RelA homodimers is activated at the time that I{kappa}B{epsilon} levels decline following B cell stimulation. In IgG+ B cell lines, which contain low levels of I{kappa}B{epsilon}, this same reporter construct was inactive, suggesting that the increases in Rel homodimer activity that accompany B cell stimulation are transient. However, there are differences in the level of expression of NF-{kappa}B-responsive genes in these IgG+ B cell lines compared with their IgM+ counterparts. From these data, we conclude that there are transient changes in NF-{kappa}B activity due to reductions in I{kappa}B{epsilon}, which might contribute to long-term, persistent changes that accompany B cell differentiation. We propose an important role for I{kappa}B{epsilon} in the differential regulation of nuclear NF-{kappa}B activity in stimulated B cells.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
V. Souvannavong, N. Saidji, and R. Chaby
Lipopolysaccharide from Salmonella enterica Activates NF-{kappa}B through both Classical and Alternative Pathways in Primary B Lymphocytes
Infect. Immun., October 1, 2007; 75(10): 4998 - 5003.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. D. Kearns, S. Basak, S. L. Werner, C. S. Huang, and A. Hoffmann
I{kappa}B{varepsilon} provides negative feedback to control NF-{kappa}B oscillations, signaling dynamics, and inflammatory gene expression
J. Cell Biol., June 5, 2006; 173(5): 659 - 664.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.